Skip to main content
Equibles
SNDX $19.84 +3.98%
SNDX logo

SNDX · Syndax Pharmaceuticals Inc

Track SNDX — free

Use SNDX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about SNDX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$19.84 +0.76 (+3.98%) At close · Aug 14
Market Cap
$1.77B
Shares
89.30M
All earnings calls

Earnings call · FY2026 Q1

Syndax Pharmaceuticals Inc Q1 FY2026 Earnings Call

Syndax Pharmaceuticals Inc Q1 FY2026 Earnings Call

Concluded Apr 30, 2026
Apr 30, 2026 0 turns
Period
FY2026 Q1
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $64.86M +223.6% YoY
Diluted EPS -$0.48
Net income -$42.67M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Apr 30, 2026 10-Q report Filed Apr 30, 2026

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Product$48.92M +144.1% YoY
Collaboration Revenue$15.94M
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)